Individuals with IgA Nephropathy have a great difference on prognosis. Some patients get complete remission in clinical, while some other patients finally have end stage renal disease (ESRD). Stage 3 IgA Nephropathy means patients’ kidneys are functioning at 30%~59%. In this case, we should try our best to avoid progression to ESRD for these patients.
IgA Nephropathy occurs because of IgA deposits, so the key of IgA Nephropathy treatment is to eliminate immune complexes, IgA, from the body and protect kidney inherent cells.
Traditional western medicines are only able to help inhibit the inflammatory reactions of IgA and help cleanse the internal environment. However, they are unable to regulate the immune system and stop the deposits of IgA completely. Meanwhile, traditional Chinese medicines are able to regulate immune system and stop the recurrence of IgA Nephropathy, but they are not so effective to cleanse the internal environment. This is the reason why IgA Nephropathy is one big problem to overcome.
From this analysis, we can know if traditional Chinese medicine and western medicine can combine, the treatment for IgA Nephropathy can get a big breakthrough. Immunotherapy is just such one therapy that absorbs the essence of western medicine and Chinese medicine.
Step one is called immune diagnosis. With unique tests, doctors can determine which type of kidney disease the patient has and the degree of damage to their kidney function.
Step two is called immune blockage. This is taken to prevent immune complexes from depositing in the kidneys.
Step three is called immune tolerance. With this step, immune complexes and kidneys can coexist safely.
Step four is called immune clearance. In this step various methods and medicines are used to cleanse immune complexes.
Step five is called immune adjustment. Since IgA Nephropathy is due to immune disorder, some methods are needed to normalize immune system.
Step six is called immune protection. Some traditional Chinese medicines are taken to protect remaining kidney functioning cells and prevent the recurrence of IgA Nephropathy.